Deflation has become a central concern these days. The Federal Reserve sweats the notion of falling prices across the economy, as it tends shrink asset values even as debts against those assets remain constant. And companies hate deflation, because it usually… Read More
David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon
Analyst Articles
A Second Chance to Buy an Industry Game-Changer
Talk about timely. Several colleagues of mine were recently discussing what investors should do when that stock you love seems like it already left the station. We ended up covering the topic on our sister site, InvestingAnswers.com. [See: “What to do When You’ve Missed the White… Read More
How to Earn an Extra $1,129.22 This Month
There are a lot of folks that visit Washington, D.C. in April to see the famous cherry blossoms. The same goes for touring New England when the leaves start to change in the fall. But one season that seems ignored despite being every bit as beautiful —… Read More
The Most Speculative Stock I’ve Ever Seen
I spend the vast majority of my time hunting down securities I believe are significantly undervalued and investigating those in great detail I believe have considerable upside potential. However, it’s also a valuable exercise to spend some time on the opposite end of the spectrum and analyze what I find… Read More
Although most of us are too young to remember, imagine what it must have been like during the Great Depression or the Second World War. Shortages at those times had most everyone scrapping for basics like sugar, butter or coffee. Such things may seem unfathomable… Read More
Experienced investors know that no trend — no matter how profitable — lasts forever. The same is true for gold. Gold has risen from below $700/oz. in November 2008 to $1,315/oz. in the beginning of October 2010. That’s an +88% gain in under two years. And while any mention of shorting gold is enough to get a gold bug’s blood boiling, one day the time will come when it’s the right trade to make. Consumer sentiment My daughter is home for a couple of months before she starts work as an attorney. When… Read More
Experienced investors know that no trend — no matter how profitable — lasts forever. The same is true for gold. Gold has risen from below $700/oz. in November 2008 to $1,315/oz. in the beginning of October 2010. That’s an +88% gain in under two years. And while any mention of shorting gold is enough to get a gold bug’s blood boiling, one day the time will come when it’s the right trade to make. Consumer sentiment My daughter is home for a couple of months before she starts work as an attorney. When I asked her if it was time to go short on gold, and she said that she hoped so. Her thought was, “If I’m shorting gold, then I believe the economy is improving, jobs are forming and a brighter future is heading our way.” And that would be terrific news for many of her friends who recently finished graduate school and are still looking for jobs. Her comments very much reflect the effect that confidence has on the economy. If things are looking up, people are willing to invest in risky assets that offer… Read More
The Fed is About to Smile on Income Investors
You’ve likely been wondering what’s going on with the market. The S&P 500 is up about +12% since the start of September, yet unemployment is still high, the U.S. deficit is still enormous and the overall economic picture is still hazy. What’s behind it all? I think most of the answer lies in QE2. No, not the Queen Elizabeth 2 ocean liner. QE2 is what the business media is calling the pending second wave of quantitative easing by the U.S. Federal Reserve. To stimulate the… Read More
You’ve likely been wondering what’s going on with the market. The S&P 500 is up about +12% since the start of September, yet unemployment is still high, the U.S. deficit is still enormous and the overall economic picture is still hazy. What’s behind it all? I think most of the answer lies in QE2. No, not the Queen Elizabeth 2 ocean liner. QE2 is what the business media is calling the pending second wave of quantitative easing by the U.S. Federal Reserve. To stimulate the economy, the U.S. Federal Reserve has set short-term interest rates at all-time lows. But the economy is still sluggish and unemployment remains stubbornly high. To further stimulate the economy, the Fed has stated that it is likely to try a little-used tool called quantitative easing. Quantitative easing is used to hold or push down long-term interest rates. To do this, the central bank buys long-term Treasury bonds, keeping their prices higher — and yields lower. The hope is that by… Read More
One of the best performing markets of the past century is read hot again this century. Warren Buffett said, “The 19th century belonged to England, the 20th century belonged to the U.S., and the 21st century belongs to China. Invest accordingly.” Maybe so, but this… Read More
Half-Off Stocks You Can’t Afford to Ignore
September and October sure have been kind to investors, with the major indices up more than +10% and some individual stocks up +30% to 40% since late August. Back then, it was easy to spot bargains after a summer swoon. Nowadays,… Read More
$38 Billion from Uncle Sam Could Send These Stocks Soaring
Perhaps the biggest domestic market opportunity for investors is the U.S. health care system. The industry already consumes roughly 16% of gross domestic product and that’s likely to reach 19.5% by 2017. Of the total spending, about half goes to hospital care and physician services. But with such large amounts, it is inevitable that there will be wasteful spending and lots of inefficiencies. A report from the Annals of Family Medicine shows that primary care physicians spend about half their work day on activities outside the exam room. Of course, this involves documentation, reporting, billing and so… Read More
Perhaps the biggest domestic market opportunity for investors is the U.S. health care system. The industry already consumes roughly 16% of gross domestic product and that’s likely to reach 19.5% by 2017. Of the total spending, about half goes to hospital care and physician services. But with such large amounts, it is inevitable that there will be wasteful spending and lots of inefficiencies. A report from the Annals of Family Medicine shows that primary care physicians spend about half their work day on activities outside the exam room. Of course, this involves documentation, reporting, billing and so on. Then again, the workflows for physicians are often problematic. They may rely on assistants who are often overwhelmed with records, regulations and rules. And the consequences can be severe. To deal with this, Congress has taken action to help reform the system. Roughly $38 billion in subsidies will be committed to aiding the speedy adoption, and improvement, of electronic medical records by 2016. This is actually part of the 2009 recovery legislation, which created the Health Information Technology for Economic and Clinical Health Act (HITECH). Basically, the law prods physicians to adopt information… Read More